Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 375 of 3173 entries
View as:

Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00068952 Org: User:
Start: 08/31/03 End: 03/31/06 Due: 03/31/07

Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years

Phase: N/A Priority: Normal
NCT ID: NCT01364571 Org: User:
Start: 08/31/11 End: 01/31/13 Due: 01/31/14

A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT00596518 Org: User:
Start: 10/31/07 End: 07/31/08 Due: 07/31/09

Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00036205 Org: User:
Start: 08/31/00 End: 12/31/04 Due: 12/31/05

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01597193 Org: User:
Start: 04/30/12 End: 01/22/18 Due: 01/22/19

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT00960440 Org: User:
Start: 10/31/09 End: 03/31/11 Due: 03/31/12

A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT05926960 Org: User:
Start: 06/13/23 End: 11/25/25 Due: 11/25/26

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France

Phase: N/A Priority: Normal
NCT ID: NCT05038228 Org: User:
Start: 08/01/22 End: 12/01/25 Due: 12/01/26

Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR

Phase: N/A Priority: Normal
NCT ID: NCT00161824 Org: User:
Start: 10/31/01 End: 01/31/02 Due: 01/31/03

Korean Post-marketing Surveillance for Xeljanz XR

Phase: N/A Priority: Normal
NCT ID: NCT04876781 Org: User:
Start: 01/12/22 End: 12/06/26 Due: 12/06/27

A Multiple Oral Doses Study Of PF-06427878 In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02391623 Org: User:
Start: 03/31/15 End: 02/29/16 Due: 02/28/17

Observational Study Of Donepezil In Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT00843115 Org: User:
Start: 02/28/07 End: 04/30/08 Due: 04/30/09

Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza

Phase: N/A Priority: Normal
NCT ID: NCT00640042 Org: User:
Start: 03/31/08 End: 12/31/08 Due: 12/31/09

Study In Patients With Kidney Cancer Treated With Sutent

Phase: N/A Priority: Normal
NCT ID: NCT00873210 Org: User:
Start: 05/31/09 End: 11/30/11 Due: 11/30/12

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01363297 Org: User:
Start: 08/31/11 End: 01/31/16 Due: 01/31/17

Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01475383 Org: User:
Start: 04/30/12 End: 04/30/12 Due: 04/30/13

Study To Investigate The Potential Drug Drug Interaction (DDI) Between PF-00299804 And Paroxetine In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01318031 Org: User:
Start: 03/31/11 End: 06/30/11 Due: 06/30/12

A Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-05230907 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01897142 Org: User:
Start: 09/30/13 End: 03/31/15 Due: 03/31/16

PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT00174356 Org: User:
Start: 12/31/02 End: 10/31/05 Due: 10/31/06

A Study To Understand How Radiolabelled PF-04449913 Is Taken Up By The Body, Broken Down And Then Removed From The Body

Phase: N/A Priority: Normal
NCT ID: NCT02110342 Org: User:
Start: 05/31/14 End: 06/30/14 Due: 06/30/15

X-Ray Study Investigating The Safety And Efficacy Of SD-6010 In Subjects With Osteoarthritis Of The Knee

Phase: N/A Priority: Normal
NCT ID: NCT01438918 Org: User:
Start: 03/31/12 End: 12/31/15 Due: 12/31/16

A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting

Phase: N/A Priority: Normal
NCT ID: NCT05452941 Org: User:
Start: 10/27/22 End: 06/04/27 Due: 06/04/28

A Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT01132690 Org: User:
Start: 08/31/10 End: 07/31/12 Due: 07/31/13

A Study to Learn About the Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC)

Phase: N/A Priority: Normal
NCT ID: NCT05463952 Org: User:
Start: 08/16/22 End: 03/31/25 Due: 03/31/26

Bioequivalence Study Comparing Artesunate Tablet To Arsuamoon® Tablets (Guilin-China) In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00894374 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10